Nestlé has agreed to purchase US-based Sweet Earth to enter plant-based protein market. Sweet Earth produces products ranging in plant-based proteins like wheat-based seitan, tofu as wells as legumes such as lentils, chickpeas and ...
Tags: Nestle, protein market
Nestlé USA has forayed into the direct-to-consumer (DTC) prepared meals business by acquiring a minority stake in Freshly. The Nestle subsidiary was the leading investor in a $77m funding round in the DTC healthy prepared meals ...
Tags: Nestle, Prepared Meals
Kruger Packaging has selected ABB to provide engineered solution and services for a paper machine rebuild project at Trois-Rivières Mill in Quebec, Canada. Kruger Packaging is investing C$250m ($188.6m) to convert the No. 10 ...
Tags: Kruger, ABB, Engineered solution, Paper machine rebuild project
It’s a long way from New York’s Madison Avenue advertising agencies to Gaborone, but for Botswana a lot is riding on the success of the ad campaign De Beers will launch in the coming weeks. Like oil-exporting countries now ...
The emissions from compressed natural gas (CNG)-run buses have the potential for causing cancers in human beings due to the presence of ‘nanocarbon’ particles. This has been revealed by a study conducted by Council of ...
Tags: CNG Vehicles, natural gas
Driven by gross margin expansion and a lower tax rate, earnings per share surged 25 per cent, year over year at sports good and sportswear marketer Nike Inc for the fiscal ending May 31, 2015. A Nike press release informed that fiscal ...
Tags: Nike, comfortable footwear, fashionable sports shoes, sports footwear
Driven by strong revenue growth and gross margin expansion, net income at sports goods marketer, Nike for the third fiscal quarter ended February 28, 2015 surged 16 percent year over year. In the third quarter of fiscal 2015, Nike said ...
Tags: sports goods, Nike, Nike brand
Nike Inc. reported earnings rose 16.0 percent in its third quarter ended Feb. 28, to $791 million, or 89 cents a share, versus Wall Street's consensus target of 84 cents. Sales rose 7.0 percent to $7.46 billion. Sales on a currency-neutral ...
Tags: Nike, Earnings, Sporting Goods
Gross margin expansion and a lower average share count drove diluted earnings per share growth by 25 per cent year on year at Nike for its second fiscal quarter ended November 30, 2014. In the second quarter of fiscal 2015, net income ...
Tags: product type, geography, key category, Apparel
Nike, Inc. reported earnings rose 22.7 percent in the second quarter ended Nov. 30, to $655 million, or 74 cents a share, exceeding Wall Street's consensus estimate of 70 cents. Revenues grew 14.8 percent to $7.38 billion. Nike Brand ...
Tags: product type, geography and key category, Sporting Goods
Truett-Hurst today reported results for its first quarter fiscal 2015 (FY15), which ended 30 September 2014. Truett-Hurst operates an innovative and fast growing super-premium and ultra-premium wine sales, marketing and production company ...
Tags: DTC net sales, wine club sales, room sales, Agriculture
The total wholesale value of the branded athletic footwear market reached $46,515 million in 2013 compared to $44,462 million the prior year, considerably aided by the big boost in Nike’s U.S. basketball business. That helped overcome ...
Deckers Outdoor Corp. promoted Dave Powers, currently president, global direct-to-consumer (DTC), to president of omni-channel, reporting to the CEO. In addition to continuing to oversee Deckers' domestic DTC operations, he will also ...
Tags: DTC, UGG, E-Commerce channel, Omni-Channel strategy
Close to 16 percent, or 37 million of adults agree that paying more for branded prescription medications rather than getting generic products, according to Kantar Media's 2013 OTC/DTC Study. Forty-five percent or 106 million adults ...
Tags: Branded Medications, Generic Products, Adults Preferences OTC/DTC
Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...